ArticleOpen forum infectious diseases2023

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate for Nonoccupational HIV-1 Postexposure Prophylaxis: A Prospective Open-Label Trial (DORAVIPEP).

Alexy Inciarte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.